Search results for "Opium"

showing 10 items of 168 documents

CCDC 1907944: Experimental Crystal Structure Determination

2019

Related Article: Maria-Gabriela Alexandru, Diana Visinescu, Beatrice Braun-Cula, Sergiu Shova, Francesc Lloret, Miguel Julve|2019|Dalton Trans.|48|7532|doi:10.1039/C9DT01445D

Space GroupCrystallographyCrystal Systemtetrakis(mu-cyano)-tetranitrato-dicyano-bis(triphenylphosphine oxide)-bis(2-(pyridin-2-yl)imidazolyl)-bis(hydrogen tris(pyrazolyl)borate)-di-iron-di-europium acetonitrile solvateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2089885: Experimental Crystal Structure Determination

2021

Related Article: Valentina V. Utochnikova, Andrey N. Aslandukov, Andrey A. Vashchenko, Alexander S. Goloveshkin, Alexey A. Alexandrov, Raitis Grzibovskis, Jean-Claude G. Bünzli|2021|Dalton Trans.|50|12806|doi:10.1039/D1DT02269E

Space GroupCrystallographyCrystal Systemtris(acetylacetonato)-(47-diphenyl-110-phenanthroline)-europium(iii)Crystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 953139: Experimental Crystal Structure Determination

2014

Related Article: Sara Rodríguez, Perla Elizondo, Sylvain Bernès, Nancy Pérez, Ricardo Bustos, Enrique García-España|2015|Polyhedron|85|10|doi:10.1016/j.poly.2014.08.041

Space GroupCrystallographyDiaqua-tris(nitrato)-bis(22'-(pyridine-26-diylbis(methyleneoxy))dibenzaldehyde)-europiumCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1453997: Experimental Crystal Structure Determination

2016

Related Article: Jashobanta Sahoo, Rajendran Arunachalam, Palani S. Subramanian, Eringathodi Suresh, Arto Valkonen, Kari Rissanen, Markus Albrecht|2016|Angew.Chem.,Int.Ed.|55|9625|doi:10.1002/anie.201604093

Space GroupCrystallographybis(mu-N'1-((pyridin-2-yl)methylene)-N'4-((pyridin-2-yl)methylene)succinohydrazide)-bis(nitrato)-tetra-aqua-di-europium(iii) tetranitrate tetrahydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1833445: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-((mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-diaqua-europium bromide trifluoromethanesulfonate hydrate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 764597: Experimental Crystal Structure Determination

2010

Related Article: D.Visinescu, O.Fabelo, C.Ruiz-Perez, F.Lloret, M.Julve|2010|CrystEngComm|12|2454|doi:10.1039/c002305a

Space GroupCrystallographytetrakis(mu~2~-Cyano)-(mu~2~-22'-bipyrimidine)-hexa-aqua-dodecacyano-bis(nitrato-OO')-tetrakis(110-phenanthroline-NN')-di-europium(iii)-tetra-iron(iii) octahydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1962564: Experimental Crystal Structure Determination

2020

Related Article: Matias Zapata-Lizama, Patricio Hermosilla-Ibáñez, Diego Venegas-Yazigi, Guillermo Mínguez Espallargas, Lauro June Queiroz Maia, Gisane Gasparotto, Ricardo Costa De Santana, Walter Cañón-Mancisidor|2020|Inorg.Chem.Front.|7|3049|doi:10.1039/D0QI00232A

Space GroupCrystallographytris(tetra-n-butylammonium) (mu-hydroxo)-tricosakis(mu-oxo)-(mu-phosphato)-undecaoxo-bis(110-phenanthroline)-europium-undeca-tungsten monohydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Magnetic Ordering and Spin Dynamics of Ba1-xEuxSi Phases

2011

We have investigated the magnetic ordering and spin dynamics of the solid solution series Ba1–xEuxSi with 0 < x ≤ 1 applying X-ray diffraction, electric conductivity measurements, Mossbauer spectroscopy, muon spin depolarization, and neutron diffraction. Our results suggest a spin glass-like behavior of Ba1–xEuxSi for concentrations close to x = 0.3 exist. Different spin ordering phenomena are found, which are dependent on the relative europium concentrations.

Spin glassCondensed matter physicsSpin polarizationChemistryNeutron diffractionchemistry.chemical_elementMuon spin spectroscopy010402 general chemistry01 natural sciences0104 chemical sciencesInorganic ChemistrySpin wave0103 physical sciences010306 general physicsEuropiumSpin-½Solid solutionZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
researchProduct

Binding Sites, Vibrations and Spin-Lattice Relaxation Times in Europium(II)-Based Metallofullerene Spin Qubits.

2021

Abstract To design molecular spin qubits with enhanced quantum coherence, a control of the coupling between the local vibrations and the spin states is crucial, which could be realized in principle by engineering molecular structures via coordination chemistry. To this end, understanding the underlying structural factors that govern the spin relaxation is a central topic. Here, we report the investigation of the spin dynamics in a series of chemically designed europium(II)‐based endohedral metallofullerenes (EMFs). By introducing a unique structural difference, i. e. metal‐cage binding site, while keeping other molecular parameters constant between different complexes, these manifest the ke…

Spin statesFOS: Physical scienceschemistry.chemical_element010402 general chemistry01 natural sciencesMolecular physicsCatalysischemistry.chemical_compoundVery Important PaperPhysics - Chemical PhysicsPhysics::Atomic and Molecular ClustersPhysics - Atomic and Molecular Clustersspin-vibration couplingQuantumeuropiumSpin-½Chemical Physics (physics.chem-ph)Full Paper010405 organic chemistryChemistryNanotecnologiaOrganic ChemistryRelaxation (NMR)Spin–lattice relaxationfullerenesGeneral ChemistryQuímicaFull Papers0104 chemical sciences3. Good healthQubitMetallofullerenemagnetic propertiesAtomic and Molecular Clusters (physics.atm-clus)Europiumspin qubitsChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.

2014

BackgroundTiotropium, a once-daily long-acting anticholinergic bronchodilator, has demonstrated efficacy in patients with asthma who were symptomatic despite treatment with medium- to high-dose inhaled corticosteroids (ICS).ObjectiveThe objective of this study was to evaluate the efficacy and safety of once-daily tiotropium Respimat (5 μg or 2.5 μg), compared with placebo Respimat, as add-on therapy to low- to medium-dose ICS for adults with symptomatic asthma.MethodsA phase III, double-blind, placebo-controlled trial was conducted (NCT01316380). Adults with symptomatic asthma receiving low- to medium-dose ICS (200-400 μg budesonide or equivalent dose) and a pre-bronchodilator forced expira…

SpirometryBudesonideAdultMaleRespimatmedicine.drug_classSymptomaticAnticholinergicMildPlacebo03 medical and health sciences0302 clinical medicineBronchodilatorsAdrenal Cortex HormonesBronchodilatorControlAdministration InhalationImmunology and AllergyMedicineHumans030212 general & internal medicineTiotropium BromideBudesonideAnticholinergic; Asthma; Bronchodilators; Control; GINA; ICS; Mild; Respimat; Symptomatic; Tiotropium; Administration Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Bronchodilator Agents; Budesonide; Disease Progression; Drug Combinations; Female; Humans; Male; Placebo Effect; Spirometry; Tiotropium Bromide; Treatment Outcome; Immunology and AllergyAsthmamedicine.diagnostic_testbusiness.industryTiotropiumTiotropium bromidemedicine.diseasePlacebo EffectGINAAsthmarespiratory tract diseasesRespimatBronchodilator AgentsDrug CombinationsTreatment OutcomeInhalation030228 respiratory systemTolerabilityICSSpirometryAnesthesiaAdministrationDisease ProgressionFemalebusinessmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct